Stem Cell Therapy in Heart Failure

Abstract

Heart related disease are among leading causes of death worldwide, but there are few efficient treatments available. Stem cells possess excellent potential because therapeutic methods now enhance patient quality of life and address comorbidities. A growing corpus of research demonstrates that local cardiac stem cells are activated to rejuvenate the heart. Recent clinical trials seem to confirm that stem cell therapy for people with persistent heart failure is safe. Along with the most effective pharmacological and technology therapies, stem cell therapy may improve NT-proBNP, exercise tolerance, and cardiac function. However, following a severe heart injury, the heart's intrinsic ability to regenerate is insufficient to facilitate healing. With stem cell therapy, the risk of fatal heart attacks and strokes is reduced by 65%. In some heart failure patients, stem cell therapy has been found to lower the risk of heart attack and stroke. More research on the effectiveness and safety of these medications is needed before they can be used more frequently.